key drivers and challenges of the global interventional cardiology market

Cardiovascular disease (CVD) is a class of diseases that involve the heart or blood vessels. Smoking and tobacco consumption, high blood pressure, stress, obesity, and irregular sleep patterns are leading causes of cardiovascular diseases such as coronary artery disease, myocardial infarction (heart attack), congenital heart disease and rheumatic heart disease which in turn are among the leading causes of death globally.

According to the research conducted by Netscribes, the global interventional cardiology market is expected to expand at a compound annual growth rate (CAGR) of 7% and generate USD 23.39 Bn in revenue by 2023. The global interventional cardiology market provides a range of treatment options using cardiac intervention instruments such as catheters, stents, valves, and angioplasty balloons.

The way in which cardiovascular diseases are being treated has changed in the past few years. New drugs and advanced therapies have been introduced to help people live longer and better lives. Increasing geriatric population and obesity are among the leading causes of cardiovascular diseases. Interventional cardiology devices help cardiologists perform complicated procedures quickly. Stents dominated the global market for interventional cardiology with a 27% market share in 2017. Stents provide many benefits such as improved blood flow, rapid return to normalcy and brief hospitalization period. The continuous innovation, improvement, and advancement in the interventional cardiology devices market are fueling the global market for interventional cardiology.

Globally, governments are trying to spread awareness about the need for regular medical check-ups and the dangers of cardiovascular diseases which is creating lucrative opportunities for the growth of the global market for interventional cardiology market. Despite these growth opportunities, the high manufacturing costs of these devices, unavailability of effective first-line treatment and stringent regulations imposed on interventional cardiology devices will act as roadblocks to the smooth growth of the market in the coming years.